CHF Solutions (NASDAQ:CHFS) is scheduled to be releasing its earnings data before the market opens on Tuesday, March 2nd. Persons that are interested in registering for the company’s earnings conference call can do so using this link.
CHFS opened at $8.84 on Tuesday. CHF Solutions has a twelve month low of $5.80 and a twelve month high of $37.50. The company has a 50-day simple moving average of $8.65 and a 200 day simple moving average of $4.93. The stock has a market capitalization of $24.19 million, a price-to-earnings ratio of -0.18 and a beta of 1.55.
CHFS has been the subject of several research analyst reports. Maxim Group reissued a “buy” rating on shares of CHF Solutions in a research note on Thursday, November 12th. Zacks Investment Research raised CHF Solutions from a “sell” rating to a “hold” rating in a research note on Tuesday, January 12th.
CHF Solutions, Inc, a medical device company, focuses on developing, manufacturing, and commercializing devices used in ultrafiltration therapy. The company's commercial product is the Aquadex FlexFlow System, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization.
Further Reading: Trading on Margin
Receive News & Ratings for CHF Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CHF Solutions and related companies with MarketBeat.com's FREE daily email newsletter.